J&J said it temporarily paused the use of the heart device, Varipulse, while it probes the cause of four reported “neurovascular events” in patients. J&J said the pause doesn’t affect ...

"US pulsed field ablation market revenue exceeds $500m in 2024" was originally created and published by Medical Device ...

Tectonic Therapeutic, Inc.'s stock surged 120% on positive Phase 1b data for TX45 in treating PH-HFpEF, offering a potential ...

Heart Valve Frame Market share is projected at a CAGR 9.44% during forecast period 2025 - 2032. Development of biodegradable and biocompatible frames. Growth of 3D-printed valve frames for ...